National Planning Corporation’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-35,513
Closed -$2.17M 394
2017
Q3
$2.17M Sell
35,513
-212
-0.6% -$12.9K 0.18% 123
2017
Q2
$2.19M Buy
35,725
+2,285
+7% +$139K 0.17% 145
2017
Q1
$2.03M Sell
33,440
-1,291
-4% -$78.3K 0.15% 144
2016
Q4
$2.13M Sell
34,731
-835
-2% -$48.9K 0.17% 128
2016
Q3
$2.04M Sell
35,566
-5,217
-13% -$305K 0.16% 135
2016
Q2
$2.27M Sell
40,783
-8,133
-17% -$433K 0.18% 120
2016
Q1
$2.5M Sell
48,916
-22,846
-32% -$1.12M 0.22% 103
2015
Q4
$3.38M Buy
71,762
+24,273
+51% +$1.22M 0.28% 84
2015
Q3
$2.52M Sell
47,489
-1,564
-3% -$83.1K 0.23% 94
2015
Q2
$2.7M Buy
49,053
+2,704
+6% +$152K 0.24% 90
2015
Q1
$2.67M Sell
46,349
-15,359
-25% -$870K 0.24% 92
2014
Q4
$3.63M Sell
61,708
-5,851
-9% -$326K 0.26% 72
2014
Q3
$3.86M Buy
67,559
+4,723
+8% +$265K 0.29% 67
2014
Q2
$3.47M Buy
62,836
+6,529
+12% +$356K 0.27% 73
2014
Q1
$3.03M Sell
56,307
-867
-2% -$44.9K 0.26% 74
2013
Q4
$2.74M Buy
57,174
+7,283
+15% +$333K 0.24% 92
2013
Q3
$2.33M Buy
49,891
+14,557
+41% +$665K 0.23% 100
2013
Q2
$1.57M Buy
+35,334
New +$1.58M 0.19% 118

Other funds holding MRK

National Planning Corporation's MRK Position: Q4 2017 in Review

National Planning Corporation sold out of Merck (MRK) in Q4 2017, closing a stake of 35,513 shares — an estimated $2.17M sold.

National Planning Corporation first reported a position in MRK in Q2 2013 and held it in 18 quarters. The position peaked at $3.86M in Q3 2014. 2,008 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • National Planning Corporation reported no remaining Merck position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 35,513 Merck shares in Q4 2017, an estimated $2.17M.
  • National Planning Corporation first reported a position in Merck in Q2 2013 and held it in 18 quarters.
  • National Planning Corporation's Merck position peaked at $3.86M in Q3 2014.
  • 2,008 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.